(Q42495794)

1 November 2017

title

The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample (English)

1 reference

1 November 2017

1 reference

Antonio Drago

1

0 references

Alessandro Serretti

object named as

Alessandro Serretti

series ordinal

3

0 references

author name string

Concetta Crisafulli

series ordinal

2

1 reference

1 November 2017

publication date

11 October 2011

1 reference

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

1 November 2017

published in

1 reference

1 November 2017

volume

156B

1 reference

1 November 2017

issue

8

1 reference

1 November 2017

page(s)

975-986

1 reference

Genomewide association study of movement-related adverse antipsychotic effects

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Lack of association between antipsychotic-induced Parkinsonism or its subsymptoms and rs4606 SNP of RGS2 gene in African-Caribbeans and the possible role of the medication: the Curacao extrapyramidal syndromes study X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Efficacy of atypical antipsychotics in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Glycolysis: a bioenergetic or a survival pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

An instrumental study of the relationship between extrapyramidal signs and psychosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Association of RGS2 and RGS5 variants with schizophrenia symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Tardive dyskinesia and new antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Ebf gene function is required for coupling neuronal differentiation and cell cycle exit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Sociodemographic and treatment related variables are poor predictors of haloperidol induced motor side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

21 January 2018

Neuroleptic intolerance

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: results from the Juntendo University Schizophrenia Projects (JUSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Statistical methods for pathway analysis of genome-wide data for association with complex genetic traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Atypical antipsychotic tolerability and switching strategies in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Zinc finger protein ZNF202 structure and function in transcriptional control of HDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

STEP-BD and bipolar depression: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Designing naturalistic prospective studies of economic and effectiveness outcomes associated with novel antipsychotic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Ventral mesencephalon-enriched genes that regulate the development of dopaminergic neurons in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

The SNP ratio test: pathway analysis of genome-wide association datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

Evidence That Early Extrapyramidal Symptoms Predict Later Tardive Dyskinesia: A Prospective Analysis of 10,000 Patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31245

21 January 2018

Identifiers

DOI

10.1002/AJMG.B.31245

1 reference

1 November 2017

1 reference